
HIV Research Reagents
Human immunodeficiency virus (HIV) infections in the United States continue to be a major public health concern. There are an estimated 1.2 million American people living with HIV (PLWH), and 1 out of 8 people with HIV do not know they have it. HIV also remains one of the world’s most serious health and development challenges.
The UNAIDS 2019 Report stated that there were 37.9 million PLWH globally with 1.7 million new HIV diagnoses and 770,000 deaths associated with AIDS-related illness during that year. Major global efforts have been mounted to address the HIV epidemic in the last 20 years and significant progress has been made. The number of people newly infected with HIV, and the number of deaths associated with AIDS-related illness have declined over the years, and the number of PLWH receiving treatment increased to 25.4 million in 2019.
HIV attacks the body’s immune system and if not treated, can lead to AIDS (acquired immunodeficiency syndrome). HIV and tuberculosis (TB) are the world’s two most deadly infectious diseases. Tragically, these two epidemics are interconnected, as TB is the leading cause of death for those living with HIV. The SARS-coronavirus-2 pandemic has focused research away from these other pathogens (Funding Opportunity Announcement Number: NOT-AI-21-057 – When pandemics collide).
Where did HIV come from?
The HIV infection came from a species of chimpanzee in Central Africa. The chimpanzee version of the virus is called SIV, or simian immunodeficiency virus, and was speculated to have passed to humans when humans hunted these chimpanzees for their meat and came in contact with their blood.
HIV Research
ProSci offers research reagents for HIV, including antibodies and recombinant proteins to support the ongoing study of HIV.
Explore our HIV antibodies and recombinant proteins below:
Antibodies
Product | Cat. No. | Application | Clonality | Species |
---|---|---|---|---|
HIV-1 p24 Antibody [8G9] | PM-6335 | E, WB | Monoclonal | Mouse |
HIV-1 p24 Antibody [8G9] (biotin) | PM-6335-biotin | E, WB | Monoclonal | Mouse |
HIV-1 p24 Antibody [8G9] (HRP) | PM-6335-HRP | E, WB | Monoclonal | Mouse |
HIV-1 p24 Antibody [7F4] | PM-6585 | E, WB | Monoclonal | Mouse |
HIV-1 p24 Antibody [7F4] (biotin) | PM-6585-biotin | E, WB | Monoclonal | Mouse |
HIV-1 p24 Antibody [7F4] (HRP) | PM-6585-HRP | |||
HIV-1 p24 Antibody | 7313 | E, WB | Polyclonal | Rabbit |
HIV1 p24 Antibody | 35-269 | WB | Polyclonal | Goat |
HIV1 p24 Antibody (FITC) | 35-270 | WB | Polyclonal | Goat |
HIV1 p24 Antibody (HRP) | 35-271 | WB | Polyclonal | Goat |
HIV1 p24 Antibody (biotin) | 35-272 | WB | Polyclonal | Goat |
gp120 Antibody | 4641 | E, WB | Polyclonal | Rabbit |
gp120 Antibody | 4777 | E, WB | Polyclonal | Goat |
HIV1 gp120 Antibody | 35-261 | WB | Polyclonal | Goat |
HIV1 gp120 Antibody (HRP) | 35-263 | WB | Polyclonal | Goat |
HIV1 gp120 Antibody (biotin) | 35-264 | WB | Polyclonal | Goat |
HIV-1 (HTLV-3) Antibody | 35-257 | WB | Polyclonal | Goat |
HIV-1 (HTLV-3) Antibody (FITC) | 35-258 | WB | Polyclonal | Goat |
HIV-1 (HTLV-3) Antibody (HRP) | 35-259 | WB | Polyclonal | Goat |
HIV-1 (HTLV-3) Antibody (biotin) | 35-260 | WB | Polyclonal | Goat |
HIV1 gp41 Antibody | 35-265 | WB | Polyclonal | Goat |
HIV1 gp41 Antibody (HRP) | 35-267 | WB | Polyclonal | Goat |
HIV1 gp41 Antibody (biotin) | 35-268 | WB | Polyclonal | Goat |
HIV-Rev Antibody | XW-8152 | WB | Polyclonal | Chicken |
Gag polyprotein Antibody | XW-8151 | WB | Polyclonal | Chicken |
HIV Antibody [1911] | 35-542 | E, WB | Monoclonal | Mouse |
HIV Antibody [1941] | 35-543 | E, WB, IHC, IF | Monoclonal | Mouse |
HIV Antibody [1941] (FITC) | 35-544 | E, WB, IHC, IF | Monoclonal | Mouse |
HIV Antibody [1946] | 35-545 | E, IF | Monoclonal | Mouse |
HIV Antibody [1947] | 35-546 | E, IF | Monoclonal | Mouse |
HIV Antibody [1949] | 35-548 | E, IF | Monoclonal | Mouse |
Recombinant Proteins
Product | Cat. No. | Source | Fusion Tag | Sequence |
---|---|---|---|---|
HIV-1 nef Recombinant Protein | 53-339 | E. coli | Beta-galactosidase | Amino Acids 3 - 190 |
HIV-1 gp4l Recombinant Protein | 53-340 | E. coli | Beta-galactosidase | Full Length |
HIV-1 p24 Recombinant Protein | 53-341 | P. pastoris | None | Full Length |
HIV-1 gp41 Recombinant Protein | 53-342 | P. pastoris | None | Amino Acids 546 - 682 of HxB2 |
HIV-2 gp36 Recombinant Protein | 53-343 | P. pastoris | None | A portion of GP 36 |
HIV-2 gp36 Recombinant Protein | 53-344 | E. coli | Beta-galactosidase | Full Length |
HIV GP120 Recombinant Protein | 96-365 | HEK293 Cells | His Tag | Thr36 - Lys511 |
HIV GP120 Recombinant Protein | 96-366 | HEK293 Cells | His Tag | Thr23 - Thr652 |
HIV GP120 Recombinant Protein | 96-367 | HEK293 Cells | His Tag | Thr34 - Arg506 |
More Infectious Disease Targets
Downloadable Resources